Editorial (19)
11421.
Editorial
1839 (8), S. 621 - 622 (2014)
Molecular mechanisms of histone modification function. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms 11422.
Editorial
20, S. v - vii (2014)
Molecular imaging. Current Opinion in Chemical Biology 11423.
Editorial
71 (3), S. 901 - 902 (2014)
Magnetic resonance in medicine at 30. Magnetic Resonance in Medicine 11424.
Editorial
71 (3), S. 901 - 902 (2014)
Magnetic resonance in medicine at 30. Magnetic Resonance in Medicine 11425.
Editorial
12 (20), S. 3243 - 3244 (2013)
Induction of multiple cycles of pancreatic ß-cell replacement. Cell Cycle 11426.
Editorial
1833 (7), S. IV - V (2013)
Preface. The 12th meeting of the European Calcium Society. Biochimica et Biophysica Acta - Molecular Cell Research 11427.
Editorial
15 (39), S. 16976 - 16977 (2013)
Comment on “On the dual emission of p-dimethylaminobenzonitrile and its photophysical implications”. Physical Chemistry Chemical Physics 11428.
Editorial
380 (9849), S. 1280 - 1280 (2012)
Bulla in the lung. The Lancet 11429.
Editorial
1813 (5), S. 909 - 912 (2011)
Calcium waves in Warszawa. Biochimica et Biophysica Acta-Molecular Cell Research 11430.
Editorial
29 (10), S. 483 - 485 (1989)
Natural-science and clinical research. Radiologe 11431.
Editorial
86 (3), S. 132 - 133 (1986)
Experiments with animals and biomedical-research. Die Umschau 11432.
Editorial
80, S. 153 - 159 (1985)
Adult heart muscle cells - Isolation, properties and applications. Basic Research in Cardiology Manuskript (3)
11433.
Manuskript
Do inhibitors targeted against mutant oncogenic kinases act via kinase degradation-induced immune activation? (2021)
11434.
Manuskript
Proposed mechanism for thrombotic thrombocytopenia induced by adenovirus-based COVID-19 vaccines. (2021), 4 S.
11435.
Manuskript
The immune activation model for targeted inhibitors of mutated oncogenic kinases. (2021)
Patent (5)
11436.
Patent
Medicaments. US 08389555 (2013)
11437.
Patent
Dual-mode microwave resonator device and method of electron spin resonance measurement. EP 2486416 B1 (2013)
11438.
Patent
Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine. US 08354430 (2013)
11439.
Patent
Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
11440.
Patent
New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)